Epilepsy And Alzheimer’s Research May Benefit From The Solving Of A Molecular Mystery
Carnegie Mellon University chemists have solved a decade-long molecular mystery that could eventually help scientists develop drug therapies to treat a variety of disorders, including epilepsy and Alzheimer’s disease.
